The role of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in chronic obstructive pulmonary disease. - Mah JSY; Eng PC; Izzi-Engbeaya C; Finney LJ (Expert review of clinical immunology, 2026)